X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1454) 1454
venoocclusive disease (1087) 1087
male (916) 916
female (736) 736
hematology (684) 684
transplantation (628) 628
hepatic venoocclusive disease (623) 623
adult (588) 588
bone-marrow-transplantation (554) 554
oncology (550) 550
middle aged (502) 502
liver (429) 429
adolescent (401) 401
immunology (392) 392
child (342) 342
stem-cell transplantation (278) 278
child, preschool (271) 271
veno-occlusive disease (264) 264
treatment outcome (251) 251
aged (248) 248
hematopoietic stem cell transplantation - adverse effects (247) 247
busulfan (246) 246
hematopoietic stem cells (246) 246
risk factors (245) 245
animals (239) 239
toxicity (229) 229
children (225) 225
infant (222) 222
hematopoietic stem cell transplantation (218) 218
transplantation, homologous (211) 211
versus-host-disease (211) 211
bone-marrow transplantation (208) 208
stem cells (199) 199
chemotherapy (197) 197
retrospective studies (195) 195
hepatic veno-occlusive disease - etiology (193) 193
diagnosis (191) 191
busulfan - administration & dosage (171) 171
pharmacology & pharmacy (170) 170
cyclophosphamide (160) 160
pediatrics (160) 160
gastroenterology & hepatology (157) 157
pharmacokinetics (157) 157
health aspects (155) 155
bone marrow transplantation - adverse effects (147) 147
sinusoidal obstruction syndrome (146) 146
cancer (144) 144
bone marrow transplantation (141) 141
pulmonary hypertension (136) 136
leukemia (135) 135
young adult (135) 135
therapy (134) 134
respiratory system (133) 133
surgery (129) 129
transplantation conditioning - methods (126) 126
analysis (125) 125
care and treatment (119) 119
hepatic veno-occlusive disease - chemically induced (119) 119
busulfan - pharmacokinetics (117) 117
prognosis (116) 116
risk-factors (115) 115
total-body irradiation (112) 112
research (111) 111
stem cell transplantation (110) 110
mortality (108) 108
liver - pathology (107) 107
rats (102) 102
hematopoietic stem cell transplantation - methods (101) 101
complications and side effects (98) 98
defibrotide (97) 97
hepatotoxicity (97) 97
toxicology (97) 97
hematology, oncology and palliative medicine (95) 95
time factors (92) 92
medicine & public health (91) 91
bone marrow (90) 90
urology & nephrology (90) 90
radiology, nuclear medicine & medical imaging (89) 89
hypertension (88) 88
incidence (88) 88
liver diseases (88) 88
antineoplastic agents - adverse effects (87) 87
pyrrolizidine alkaloids (87) 87
pathology (86) 86
survival analysis (86) 86
medicine, general & internal (85) 85
survival rate (84) 84
antineoplastic combined chemotherapy protocols - therapeutic use (83) 83
prevention (83) 83
transplantation conditioning - adverse effects (83) 83
acute myeloid-leukemia (81) 81
liver - drug effects (81) 81
graft vs host disease - etiology (80) 80
hepatic veno-occlusive disease - diagnosis (80) 80
prospective studies (80) 80
transplantation conditioning (80) 80
blood (79) 79
hematologic neoplasms - therapy (78) 78
complications (77) 77
hepatic veno-occlusive disease - drug therapy (77) 77
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1994) 1994
French (31) 31
German (25) 25
Spanish (13) 13
Japanese (3) 3
Russian (3) 3
Portuguese (2) 2
Turkish (2) 2
Croatian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2009, Volume 54, Issue 1, pp. S43 - S54
The aim of a clinical classification of pulmonary hypertension (PH) is to group together different manifestations of disease sharing similarities in pathophysiologic mechanisms, clinical presentation, and therapeutic approaches... 
Cardiovascular | Internal Medicine | clinical classification | pulmonary arterial hypertension | pulmonary hypertension | VENOOCCLUSIVE-DISEASE | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | HEREDITARY HEMORRHAGIC TELANGIECTASIA | CONNECTIVE-TISSUE-DISEASE | SYSTEMIC-SCLEROSIS | INTERSTITIAL LUNG-DISEASE | GLYCOGEN-STORAGE-DISEASE | ARTERIAL-HYPERTENSION | SICKLE-CELL-DISEASE | OF-THE-LITERATURE | Hypertension, Pulmonary - classification | Prognosis | Comorbidity | Humans | Calcium Channel Blockers - therapeutic use | Antihypertensive Agents - administration & dosage | Anticoagulants - therapeutic use | Treatment Outcome | Hypertension, Pulmonary - epidemiology | Evidence-Based Medicine | Scleroderma, Systemic - epidemiology | Randomized Controlled Trials as Topic | Algorithms | Hypertension, Pulmonary - drug therapy | Endothelin Receptor Antagonists | Epoprostenol - administration & dosage | Hypertension | Medical colleges | Micropollutants | Sickle cell anemia | Architecture | Respiratory agents | Congenital heart disease | HIV (Viruses) | Peptide hormones | Coronary heart disease | Gene mutations | Bone morphogenetic proteins | Kidney diseases | Cardiology | Health aspects | Personal video recorders | Anemia | Pulmonary hypertension | Genetic counseling | Surgery | Classification | Clinical trials | Cardiovascular disease | Mutation | Family medical history | Drug therapy | Defects
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2013, Volume 57, Issue 3, pp. 1078 - 1087
Journal Article
British journal of haematology, ISSN 0007-1048, 2015, Volume 168, Issue 4, pp. 481 - 491
Summary Sinusoidal obstruction syndrome (SOS), also called veno‐occlusive disease of the liver, is one of the most relevant complications of endothelial origin that appears early after haematopoietic cell transplantation (HCT... 
endothelial damage | defibrotide | sinusoidal obstruction syndrome | early complications post‐HCT | veno‐occlusive disease of the liver | Endothelial damage | Sinusoidal obstruction syndrome | Early complications post-HCT | Veno-occlusive disease of the liver | Defibrotide | VENOCCLUSIVE DISEASE | veno-occlusive disease of the liver | REGIMEN-RELATED TOXICITIES | LOW-DOSE HEPARIN | BONE-MARROW-TRANSPLANTATION | RANDOMIZED-TRIAL | early complications post-HCT | PLASMINOGEN-ACTIVATOR | URSODEOXYCHOLIC ACID | HEPATIC VENOOCCLUSIVE DISEASE | ENDOTHELIAL-CELLS | CONTINUOUS-INFUSION | HEMATOLOGY | Fluid Therapy | Hepatic Veno-Occlusive Disease - physiopathology | Diagnosis, Differential | Hepatic Veno-Occlusive Disease - etiology | Methylprednisolone - therapeutic use | Humans | Risk Factors | Symptom Assessment | Hematopoietic Stem Cell Transplantation | Endothelium, Vascular - drug effects | Polydeoxyribonucleotides - therapeutic use | Combined Modality Therapy | Hepatic Veno-Occlusive Disease - diagnosis | Hepatic Veno-Occlusive Disease - therapy | Multiple Organ Failure - prevention & control | Multiple Organ Failure - etiology | Endothelium, Vascular - pathology | Transplantation Conditioning - adverse effects | Disease Management | Transplantation Conditioning - methods | Drug Therapy, Combination | Early Diagnosis | Transplantation | Liver diseases | Health aspects | Hematopoietic stem cells
Journal Article
Journal Article
Journal Article
Critical care medicine, ISSN 0090-3493, 09/2006, Volume 34, Issue 9 Suppl, pp. S251 - S267
OBJECTIVE:To review the available clinical data on the critical care complications of hematopoietic stem cell transplantation (HSCT). DATA SOURCE:The MEDLINE... 
Critical care | Complications | Outcome | Hematopoietic stem cell transplantation | complications | IDIOPATHIC PNEUMONIA SYNDROME | BONE-MARROW-TRANSPLANTATION | critical care | ACUTE-RENAL-FAILURE | THROMBOTIC THROMBOCYTOPENIC PURPURA | VERSUS-HOST-DISEASE | DIFFUSE ALVEOLAR HEMORRHAGE | INVASIVE PULMONARY ASPERGILLOSIS | HEPATIC VENOOCCLUSIVE DISEASE | hematopoietic stem cell transplantation | OBLITERANS ORGANIZING PNEUMONIA | outcome | RESPIRATORY SYNCYTIAL VIRUS | CRITICAL CARE MEDICINE | Critical Care - methods | Humans | Kidney Diseases - diagnosis | Gastrointestinal Diseases - etiology | Lung Diseases - therapy | Opportunistic Infections - therapy | Nervous System Diseases - diagnosis | Gastrointestinal Diseases - diagnosis | Lung Diseases - etiology | Opportunistic Infections - etiology | Liver Diseases - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Intensive Care Units | Lung Diseases - diagnosis | Liver Diseases - therapy | Gastrointestinal Diseases - therapy | Hematologic Diseases - diagnosis | Hematologic Diseases - therapy | Nervous System Diseases - therapy | Opportunistic Infections - diagnosis | Heart Diseases - diagnosis | Heart Diseases - etiology | Heart Diseases - therapy | Hematologic Diseases - etiology | Kidney Diseases - therapy | Nervous System Diseases - etiology | Liver Diseases - diagnosis | Kidney Diseases - etiology
Journal Article
Journal Article
Drug discovery today, ISSN 1359-6446, 04/2018, Volume 23, Issue 4, pp. 920 - 929
... kinases are important in cardiac and vascular homeostasis.•The ISR system might open new therapeutic windows for cardiovascular diseases... 
ISCHEMIA-REPERFUSION INJURY | ERYTHROID PRECURSORS | DIETARY-RESTRICTION | PULMONARY VENOOCCLUSIVE DISEASE | HEART-FAILURE | MOUSE MODEL | MUSCLE-CELL PROLIFERATION | PHARMACOLOGY & PHARMACY | ENDOPLASMIC-RETICULUM STRESS | REGULATED EIF2-ALPHA KINASE | SALUBRINAL PROTECTS | Cardiovascular diseases
Journal Article